Hyderabad based Pharma major Dr. Reddy’s Laboratories today posted a loss of Rs.569.7cr in the December ending quarter or Q3FY20, as against a net profit of Rs.485.2cr, while Its revenue surged to near 14 percent, year-on-year to Rs.4,384-cr in Q3FY20.
The company has recorded net sales of Rs.4383.8-Cr during the Q3 period versus Rs.3850-crores during the corresponding period year ago.
The company’s Earning per share or EPS reportedly at Rs.34.37 for the Q3 as compared to Rs.29.21 for the corresponding period year ago. Avail the Free Nifty trading tips and the latest stock trading tips from here.
At the noon session at 1.35-pm, Dr. Reddy’s Laboratories share price quoted at Rs.3,184.00-per share, up by 5.03 percent or Rs152.50 from its previous closing of Rs3,031.40. The share price also quoted its one-year-high level during intraday at Rs.3,186.15 per share today on the NSE.
Meanwhile, the Sensex scaled at 41350-level, down 262 points and the Nifty stood at 12172, down 75 points. Also, the Nifty Pharma index went up 1.53 percent with Dr. Reddy’s being the top index gainer.